Medical Innovation and Government Intervention

This book deals with the complex dynamics of the health care sector, assessing, in particular, the risks inherent with an enforced regulation of an entire industry sector. The major focus is on value creation in general and biotechnology in particular. Since drugs constitute the bulk of biotechnological health care applications, and likewise both drug development and pricing is under particular governmental regulation, the book highlights the pharmaceutical sector whenever possible. Both practioners and policy makers will find the messages in this book helpful in creating value for their stakeholders.